CN Patent

CN104337765A — 美罗培南脂质体组合药物及其大工业化生产工艺和用途

Assigned to Hunan Kangdu Pharmaceutical Co ltd · Expires 2015-02-11 · 11y expired

What this patent protects

本发明美罗培南脂质体组合药物及其大工业化制备和用途，其特征是，公开本发明的美罗培南脂质体组合药的各组份原料摩尔数比；其特征是，本发明还提供所述组质体组合药物的大工业化制备方法；其特征是，按药剂学允许的剂量，制成美罗培南脂质体组合药物的冻干针剂，或口服制剂、或喷雾剂、或栓剂。

USPTO Abstract

本发明美罗培南脂质体组合药物及其大工业化制备和用途，其特征是，公开本发明的美罗培南脂质体组合药的各组份原料摩尔数比；其特征是，本发明还提供所述组质体组合药物的大工业化制备方法；其特征是，按药剂学允许的剂量，制成美罗培南脂质体组合药物的冻干针剂，或口服制剂、或喷雾剂、或栓剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN104337765A
Jurisdiction
CN
Classification
—
Expires
2015-02-11
Drug substance claim
No
Drug product claim
No
Assignee
Hunan Kangdu Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.